Inherited Colorectal Cancer Syndromes

ABSTRACT

Colorectal cancer is one of the major causes of cancer deaths in both men and women. It is estimated that ∼5% to 10% of patients with colorectal cancer have an inherited germline mutation that predisposes them to cancer. Clinically, hereditary colorectal cancer syndromes can be divided into those associated with colonic polyposis (familial adenomatous polyposis, attenuated familial adenomatous polyposis, and MYH-associated polyposis) and those not associated with colonic polyposis (hereditary nonpolyposis colon cancer).

Treatment options for these patients include multiple aggressive screening regimens, chemopreventive medications, and prophylactic surgery. Selection of the appropriate management approach is best made using information obtained from the patient's clinical examination, the family medical history, and genetic evaluation. Compliance is improved when patients completely understand their disease and participate fully in the formulation of the treatment plan. Although not proved, it seems reasonable that this approach may prevent the poor outcomes so frequently associated with inherited cancer syndromes.

Familial adenomatous polyposis - attenuated familial polyposis - MYH-associated polyposis - hereditary nonpolyposis colon cancer

REFERENCES

• 1 Church J, McGannon E. Family history of colorectal cancer: how often and how accurately is it recorded?.  Dis Colon Rectum. 2000;  43 1540-1544
• 2 Ruo L, Cellini C, Puig-LaCalle J et al.. Limitations of family cancer history assessment at initial surgical consultation.  Dis Colon Rectum. 2001;  44 98-104
• 3 Glanz K, Grove J, LeMarchand L et al.. Underreporting of family history of colon cancer: correlates and implications.  Cancer Epidemiol Biomarkers Prev. 1999;  8 635-639
• 4 Kerber R A, Slattery M L. Comparison of self-reported and database-linked family history of cancer data in a case-control study.  Am J Epidemiol. 1997;  147 244-248
• 5 Spirio L, Olschwang S, Groden J et al.. Alleles of the APC gene: an attenuated form of familial polyposis.  Cell. 1993;  75 951-957
• 6 Hernegger G S, Moore H G, Guillem J G. Attenuated familial adenomatous polyposis: an evolving and poorly understood entity.  Dis Colon Rectum. 2002;  45 127-134
• 7 Nagase H, Nakamura Y. Mutations of the APC (adenomatous polyposis coli) gene.  Hum Mutat. 1993;  2 425-434
• 8 Church J M, McGannon E, Hull-Boiner S et al.. Gastroduodenal polyps in patients with familial adenomatous polyposis.  Dis Colon Rectum. 1992;  35 1170-1173
• 9 Giardiello F M, Brensinger J D, Luce M C et al.. Phenotypic expression in adenomatous polyposis families with mutations in the 5' region of the adenomatous polyposis coli gene.  Ann Intern Med. 1997;  126 514-519
• 10 Davies D, Armstrong J, Thakker N et al.. Severe Gardner’s syndrome in families with mutations restricted to a specific region of the APC gene.  Am J Hum Genet. 1995;  57 1151-1158
• 11 Caspari R, Olschwang S, Friedl W et al.. Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444.  Hum Mol Genet. 1995;  4 337-340
• 12 Eccles D M, VanderLuijt R, Breukel C et al.. Hereditary desmoid disease due to a frame-shift mutation at codon 1924 of the APC gene.  Am J Hum Genet. 1996;  59 1193-1201
• 13 Hendriks Y M, Wagner A, Morreau H et al.. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance.  Gastroenterology. 2004;  127 17-25
• 14 Bodmer W F, Bailey C J, Bussey H JR et al.. Localization of the gene for familial adenomatous polyposis on chromosome 5.  Nature. 1987;  328 614-616
• 15 Leppert M, Burt R, Scambler P et al.. The gene for familial polyposis coli maps to the long arm of chromosome 5.  Science. 1987;  238 1411-1412
• 16 Morin P J, Vogelstein B, Kinzler K W. Apoptosis and APC in colorectal tumorigenesis.  Proc Natl Acad Sci USA. 1996;  93 7950-7954
• 17 Fearnhead N S, Britton M P, Bodmer W F. The ABC of APC.  Hum Mol Genet. 2001;  10 721-733
• 18 Su L-K, Johnson K A, Smith K J et al.. Association between wild type and mutant APC gene products.  Cancer Res. 1993;  53 2728-2731
• 19 Al-Tassan N, Chmiel N H, Maynard J et al.. Inherited variants of MYH associated with G:C → T:A mutations in colorectal tumors.  Nat Genet. 2002;  30 227-232
• 20 Sampson J R, Dolwani S, Jones S et al.. Autosomal recessive colorectal polyposis due to inherited mutations of MYH.  Lancet. 2003;  362 39-41
• 21 Lipton L, Tomlinson I. The multiple colorectal adenoma phenotype and MYH, a base excision repair gene.  Clin Gastroenterol Hepatol. 2004;  8 633-638
• 22 Jones S, Emmerson P, Maynard J et al.. Biallelic germline mutations in MYH predispose to multiple colorectal adenomas and somatic G:C → T:A mutations.  Hum Mol Genet. 2002;  11 2961-2967
• 23 Venesio T, Molatore S, Catteno F et al.. High frequency of MYH mutations in a subset of patients with familial adenomatous polyposis.  Gastroenterology. 2004;  126 1681-1685
• 24 Lipton L, Halford S E, Johnson V et al.. Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway.  Cancer Res. 2003;  63 7595-7599
• 25 Kambara T, Whitehall V LJ, Spring K J et al.. Role of inherited defects of MYH in the development of sporadic colorectal cancer.  Genes Chromosomes Cancer. 2004;  40 1-9
• 26 Morson B C, Dawson M P. Gastrointestinal Pathology. 3rd ed. Oxford; Blackwell Scientific 1990
• 27 Church J, Lowry A, Simmang C. Practice parameters for the identification and testing of patients at risk for dominantly inherited colorectal cancer-supporting documentation.  Dis Colon Rectum. 2001;  44 1404-1412
• 28 Guillen J G, Smith A, Puig-LaCelle J et al.. Gastrointestinal polyposis syndromes.  Curr Prob Surg. 1999;  36 228-323
• 29 Petersen G M, Slack J, Nakamura Y. Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage.  Gastroenterology. 1991;  100 1658-1664
• 30 Berk T, Cohen Z, Bapat B et al.. Negative genetic test results in familial adenomatous polyposis: clinical screening implications.  Dis Colon Rectum. 1999;  42 307-310
• 31 Church J M, McGannon E, Burke C, Clark B. Teenagers with familial adenomatous polyposis: what is their risk for colorectal cancer?.  Dis Colon Rectum. 2002;  45 887-889
• 32 Tsukada K, Church J, Jagelman D G et al.. Non-cytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis.  Dis Colon Rectum. 1992;  35 29-33
• 33 Bulow S, Alm T, Fausa O et al.. Duodenal adenomatosis in familial adenomatous polyposis. DAF project group.  Int J Colorectal Dis. 1995;  10 43-46
• 34 Wallace M H, Phillips R K. Upper gastrointestinal disease in patients with familial adenomatous polyposis.  Br J Surg. 1998;  85 742-750
• 35 Groves C J, Saunders B P, Spigelman A D, Phillips R K. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study.  Gut. 2002;  50 636-641
• 36 Burke C, Church J, Beck G. The natural history of upper gastrointestinal adenomas in untreated patients with familial polyposis.  Gastrointest Endosc. 1999;  49 358-364
• 37 Spigelman A D, Phillips R KS. The upper gastrointestinal tract. In: Phillips RKS, Spigelman AD, Thompson JPS Familial Adenomatous Polyposis and Other Polyposis Syndromes. London; Edward Arnold 1994: 106-127
• 38 Jarvinen H, Nyberg M, Pettokailio P. Upper gastrointestinal tract polyps in familial adenomatous coli.  Gut. 1983;  24 333-339
• 39 Park J G, Park K J, Ahn Y O et al.. Risk of gastric cancer among Korean familial adenomatous polyposis patients.  Dis Colon Rectum. 1992;  35 996-998
• 40 Iwama T, Mishima Y, Utsunomiya J. The impact of familial adenomatous polyposis on the tumorigenesis and mortality at several organs; its rational treatment.  Ann Surg. 1993;  217 101-108
• 41 Offerhaus G J, Giardiello F M, Krush A J et al.. The risk of gastrointestinal cancer in familial adenomatous polyposis.  Gastroenterology. 1992;  102 1980-1982
• 42 Burt R W. Polyposis syndromes. In: Yamada T, Alpers DH, Oywang C, Powell DW, Silverstein FE Textbook of Gastroenterology. 2nd ed. Philadelphia; JB Lippincott 1995: 1944-1962
• 43 Watanabe H, Enjoli M, Yoa T et al.. Gastric lesions in familial adenomatous coli, their incidence and histologic analysis.  Hum Pathol. 1978;  9 269-283
• 44 Soravia C, Berk T, McLeod R S, Cohen Z. Desmoid disease in patients with familial adenomatous polyposis.  Dis Colon Rectum. 2000;  43 363-369
• 45 Scott R J, Froggat N J, Trembath R C et al.. Familial infiltrative fibromatosis (desmoid tumours) (MIMI35290) caused by a recurrent 3' APC gene mutation.  Hum Mol Genet. 1996;  5 1921-1924
• 46 Clark S K, Neale K F, Landgrebe J C et al.. Desmoid tumors complicating familial adenomatous polyposis.  Br J Surg. 1999;  86 1185-1189
• 47 Kinzbrunner B, Ritter S, Domingo J, Rosenthal C J. Remission of rapidly growing desmoid tumors after tamoxifen therapy.  Cancer. 1983;  52 2201-2204
• 48 Clark S K, Phillips R KS. Desmoids in familial adenomatous polyposis.  Br J Surg. 1996;  83 1494-1504
• 49 Reitamo J J, Scheinin T M, Hayry P. The desmoid syndrome; new aspects in the cause, pathogenesis and treatment of the desmoid tumor.  Am J Surg. 1986;  151 230-237
• 50 Bus P J, Verspaget H W, Van Krieken J H et al.. Treatment of mesenteric desmoid tumours and the anti-oestrogenic agent toremifene: case histories and an overview of the literature.  Eur J Gastroenterol Hepatol. 1999;  11 1179-1183
• 51 Rodriguez-Bigas M A, Mahoney M C, Karakousis C P, Petrelli A J. Desmoid tumors in patients with familial adenomatous polyposis.  Cancer. 1994;  74 1270-1274
• 52 Einstein D M, Taglinbue J R, Desai R K. Abdominal desmoids; CT findings in 25 patients.  AJR Am J Roentgenol. 1991;  157 275-279
• 53 Church J M. Familial adenomatous polyposis; a review.  Perspect Colon Rectal Surg. 1995;  8 203-225
• 54 Gurbuz A K, Giardiello F M, Petersen G M et al.. Desmoid tumors in familial adenomatous polyposis.  Gut. 1994;  35 377-381
• 55 Doi K, Iida M, Kohrogi N et al.. Large intra-abdominal desmoid tumors in a patient with familial adenomatous coli; their rapid growth detected by computerized tomography.  Am J Gastroenterol. 1993;  88 595-598
• 56 Penna C, Phillips R K, Tiret E et al.. Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis; experience of two European centers.  Br J Surg. 1993;  80 1027-1029
• 57 Lynch H T, Fitzgibbons R, Chong S et al.. Use of doxorubicin and dacarbazine for the management of unresectable intra-abdominal desmoid tumors in Gardner’s syndrome.  Dis Colon Rectum. 1994;  37 260-267
• 58 Bulow S, Bulow C, Nielsen T F, Karlsen L, Moesgaard F. Centralized registration, prophylactic examination, and treatment results in improved prognosis in familial adenomatous polyposis; results from the Danish Polyposis Register.  Scand J Gastroenterol. 1995;  30 989-993
• 59 Hawk E, Lubert R, Limburg P. Chemoprevention in hereditary colorectal cancer syndromes.  Cancer. 1999;  86 2551-2563
• 60 Cruz-Correa M, Hylind L M, Romans K E, Booker S V, Giardiello F M. Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study.  Gastroenterology. 2002;  122 641-645
• 61 Steinbach G, Lynch P M, Phillips R K et al.. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.  N Engl J Med. 2000;  342 1946-1952
• 62 Tonelli F, Valanzano R, Messerini L, Ficari F. Long-term treatment with sulindac in familial adenomatous polyposis: is there an actual efficacy in prevention of rectal cancer?.  J Surg Oncol. 2000;  74 15-20
• 63 Lynch H T, Thorson A G, Smyrk T. Rectal cancer after prolonged sulindac chemoprevention: a case report.  Cancer. 1995;  75 936-938
• 64 Debinski H, Love S, Spigelman A D, Phillips R K. Colorectal polyp counts and cancer in familial adenomatous polyposis.  Gastroenterology. 1996;  110 1028-1030
• 65 Church J M, Fazio V W, Lavery I C et al.. Quality of life after prophylactic colectomy and ileorectal anastomosis in patients with familial adenomatous polyposis.  Dis Colon Rectum. 1996;  39 1404-1408
• 66 Bulow C, Vasen H, Jarvinen H et al.. Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis.  Gastroenterology. 2000;  119 1454-1460
• 67 Bussey H J, Eyers A A, Ritchie S M, Thomson J P. The rectum in adenomatous polyposis: the St. Mark’s policy.  Br J Surg. 1985;  72(suppl) 529-531
• 68 Madden M V, Neale K F, Nicholls R J et al.. Comparison of morbidity and function after colectomy with ileorectal anastomosis or restorative proctocolectomy for familial adenomatous polyposis.  Br J Surg. 1991;  78 789-792
• 69 Jagelman D G. Choice of operation in familial adenomatous polyposis.  World J Surg. 1991;  15 47-49
• 70 Ambroze W L, Dozois R R, Pemberton J H et al.. Familial adenomatous polyposis: results following ileal-pouch anal anastomosis and ileorectostomy.  Dis Colon Rectum.. 1992;  35 12-15
• 71 De Cosse J J, Bulow S, Neale K et al.. Rectal cancer risk in patients treated for familial adenomatous polyposis.  Br J Surg. 1992;  79 1372-1375
• 72 Heiskanen I, Jarvinen H J. Fate of the rectal stump after colectomy and ileorectal anastomosis for familial adenomatous polyposis.  Int J Colorectal Dis. 1997;  12 9-13
• 73 Church J, Burke C, McGannon E et al.. Predicting polyposis severity by proctoscopy: how reliable is it?.  Dis Colon Rectum. 2001;  44 1249-1254
• 74 Browning S M, Nivatvongs S. Intraoperative abandonment of ileal pouch to anal anastomosis-the Mayo Clinic experience.  J Am Coll Surg. 1998;  186 441-445
• 75 Chun H K, Smith L E, Orkin B A. Intraoperative reasons for abandoning ileal pouch-anal anastomosis procedures.  Dis Colon Rectum. 1995;  38 273-275
• 76 Kartheuser A H, Parc R, Penna C P et al.. Ileal pouch-anal anastomosis as the first choice operation in patients with familial adenomatous polyposis: a ten-year experience.  Surgery. 1996;  119 615-623
• 77 Van Duijvendijk P, Slors J F, Taat C W et al.. Quality of life after total colectomy with ileorectal anastomosis or proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis.  Br J Surg. 2000;  87 590-596
• 78 van Duijvendijk P, Vasen H F, Bertario L et al.. Cumulative risk of developing polyps or malignancy at the ileal pouch-anal anastomosis in patients with familial adenomatous polyposis.  J Gastrointest Surg. 1999;  3 325-330
• 79 Remzi F H, Church J M, Bast J et al.. Mucosectomy vs. staples ileal pouch-anal anastomosis in patients with familial adenomatous polyposis: functional outcome and neoplasia control.  Dis Colon Rectum. 2001;  44 1590-1596
• 80 Fazio V W, Tjandra J J. Transanal mucosectomy. Ileal pouch advancement for anorectal dysplasia or inflammation after restorative proctocolectomy.  Dis Colon Rectum. 1994;  37 1008-1011
• 81 Ziv Y, Fazio V W, Church J M et al.. Stapled ileal pouch-anal anastomoses are safer than handsewn anastomoses in patients with ulcerative colitis.  Am J Surg. 1996;  171 320-323
• 82 Tuckson W, Lavery I, Fazio V et al.. Manometric and functional comparison of ileal pouch-anal anastomosis with and without anal manipulation.  Am J Surg. 1991;  161 90-95
• 83 Fazio V W, Ziv Y, Church J M et al.. Ileal pouch-anal anastomosis: complications and function in 1005 patients.  Ann Surg. 1995;  222 120-127
• 84 Kollmorgen C F, Nivatvongs S, Dean P A et al.. Long-term cause of death following ileal pouch-anal anastomosis.  Dis Colon Rectum. 1996;  39 525-528
• 85 Setti-Carraro P, Ritchie J K, Wilkinson K H et al.. The first 10 years experience of restorative proctocolectomy for ulcerative colitis.  Gut. 1994;  35 1070-1075
• 86 Keighley M RB, Ogunbiyi O A, Korsgen S. Pitfalls and outcome in ileo-anal pouch surgery for ulcerative colitis.  Neth J Med. 1997;  50 S23-S27
• 87 Mikkola K, Luukkonen P, Harvinene H J. Long-term results of restorative proctocolectomy for ulcerative colitis.  Int J Colorectal Dis. 1995;  10 10-14
• 88 Oresland T, Palmblad S, Ellstrom M et al.. Gynecological and sexual functions related to anatomical changes in the female pelvis after restorative proctocolectomy.  Int J Colorectal Dis. 1994;  9 77-81
• 89 Bambrick M, Fazio V W, Hull T L, Pucel G. Sexual function following restorative proctocolectomy in women.  Dis Colon Rectum. 1996;  39 610-614
• 90 McLeod R S, Baxter N N. Quality of life of patients with inflammatory bowel disease after surgery.  World J Surg. 1998;  22 375-381
• 91 Feinberg S M, Jagelman D G, Sarre R G et al.. Spontaneous resolution of rectal polyps in patients with familial polyposis following abdominal colectomy and ileorectal anastomosis.  Dis Colon Rectum. 1988;  31 169-175
• 92 Nicholls R J, Springall R G, Gallager P. Regression of rectal adenomas after colectomy and ileorectal anastomosis for familial adenomatous polyposis.  BMJ. 1988;  296 1707-1708
• 93 Penna C, Tiret E, Parc R et al.. Operation and abdominal desmoid tumors in familial adenomatous polyposis.  Surg Gynecol Obstet. 1993;  177 263-268
• 94 Modrich P, Lahue R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology.  Annu Rev Biochem. 1996;  65 101-133
• 95 deWind N, Dekker M, Berns A et al.. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation, tolerance, hyper-recombination, and predisposition to cancer.  Cell. 1995;  82 321-330
• 96 Aaltonen L A, Peltomaki P, Leach F S et al.. Clues to the pathogenesis of familial colorectal cancer.  Science. 1993;  260 812-819
• 97 Thibodeau S N, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon.  Science. 1993;  260 816-819
• 98 Ionov Y, Peinado M A, Maikhosyan S et al.. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis.  Nature. 1993;  363 558-561
• 99 Saletti P, Edwin I D, Pack K et al.. Microsatellite instability: application in hereditary non-polyposis colorectal cancer.  Ann Oncol. 2001;  12 151-160
• 100 Kuwada S K, Neklason D W, Burt R W. Biology and molecular genetics. In: Saltz LB Colorectal Cancer: Multimodality Management. Totowa, NJ; Humana 2002: 14
• 101 Parsons R, Li G M, Longley M J et al.. Hypermutability and mismatch repair deficiency in RER-cells.  Cell. 1993;  75 1227-1236
• 102 Hemminki A, Peltomaki P, Mecklin J P et al.. Loss of wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer.  Nat Genet. 1994;  8 405-410
• 103 Borresen A L, Lothe R A, McLing G I et al.. Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas.  Hum Mol Genet. 1995;  4 2065-2072
• 104 Bubb V J, Curtis L J, Cunningham C et al.. MSI and the role of hMSH2 in sporadic colorectal cancer.  Oncogene. 1996;  12 2641-2649
• 105 Herman J G, Umar A, Polyak K et al.. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.  Proc Natl Acad Sci USA. 1998;  95 6870-6875
• 106 Vasen H F, Mecklin J P, Kahn P M, Lynch H T. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).  Dis Colon Rectum. 1991;  34 424-425
• 107 Park J G, Vasen H F, Park Y J et al.. Suspected HNPCC and Amsterdam critical II: evaluation of mutation detection rate, an international collaborative study.  Int J Colorectal Dis. 2002;  17 109-114
• 108 Lynch H T, Smyrk T, Lynch J. An update of HNPCC (Lynch syndrome).  Cancer Genet Cytogenet. 1997;  93 84-99
• 109 Jass J R, Smyrk T C, Stewart S M, Lane M R, Lanspa S J, Lynch H T. Pathology of hereditary non-polyposis colorectal cancer.  Anticancer Res. 1994;  14 1631-1634
• 110 Love R R, Morrissey J F. Colonoscopy in asymptomatic individuals with a family history of colorectal cancer.  Arch Intern Med. 1984;  144 2209-2211
• 111 Jass J R, Smyrk T C, Stewart S M et al.. Pathology of hereditary nonpolyposis colorectal cancer.  Anticancer Res. 1994;  14 1631-1634
• 112 Jass J R, Pokos V, Arnold J L et al.. Colorectal neoplasms detected colonoscopically in at-risk members of colorectal cancer families stratified by the demonstration of DNA microsatellite instability.  J Mol Med. 1996;  74 547-551
• 113 Burke W, Peterson G, Lynch P et al.. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. 1. Hereditary nonpolyposis colon cancer.  JAMA. 1997;  277 915-919
• 114 Winawer S J, Fletcher R H, Miller L et al.. Colorectal cancer screening. Clinical guidelines and rationale.  Gastroenterology. 1997;  112 594-642
• 115 Vasen H F, Nagengast F M, Khan P M. Interval cancers in hereditary nonpolyposis colorectal cancer.  Lancet. 1995;  345 1183-1184
• 116 Jarvinen H J, Mecklin J P, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer.  Gastroenterology. 1995;  108 1405-1411
• 117 Jass J R, Pokos V, Arnold J L et al.. Colorectal neoplasms detected colonoscopically in at-risk members of colorectal cancer families stratified by the demonstration of DNA microsatellite instability.  J Mol Med. 1996;  74 547-551
• 118 Lin K M, Shashidharan M, Thorson A G et al.. Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer.  J Gastrointest Surg. 1998;  2 67-71
• 119 Mecklin J-P, Jarvinen H J. Clinical features of colorectal carcinoma in cancer family syndrome.  Dis Colon Rectum. 1986;  29 160-164
• 120 Lynch H T, Harris R E, Lynch P M et al.. Role of heredity in multiple primary cancer.  Cancer. 1977;  40 1849-1854
• 121 Rodriguez-Bigas M A. Prophylactic colectomy for gene carriers in hereditary nonpolyposis colorectal cancer: has the time come?.  Cancer. 1996;  78 199-201
• 122 Lynch H T, Lanspa S J, Boman B M et al.. Hereditary nonpolyposis colorectal cancer-Lynch syndromes I and II.  Gastroenterol Clin North Am. 1988;  17 679-712
• 123 Graham D M, Appelman H D. Crohn's-like lymphoid reaction in colorectal cancer: a potential histologic prognosticator.  Mod Pathol. 1990;  3 332-335
• 124 Aaltonen L A, Salovaara R, Kristo P et al.. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of screening for the disease.  N Engl J Med. 1998;  338 1481-1487
• 125 Lin K M, Shashidharan M, Ternent C A et al.. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population.  Dis Colon Rectum. 1998;  41 428-433
• 126 Lynch H T, Lanspa S J, Boman B M et al.. Hereditary nonpolyposis colorectal cancer-Lynch syndromes I and II.  Gastroenterol Clin North Am. 1988;  17 679-712
• 127 Lynch H T, Fusaro R M, Roberts L, Voorhees G J, Lynch J F. Muir-Torre syndrome in several members of a family with a variant of the cancer family syndrome.  Br J Dermatol. 1985;  113 295-301
• 128 Lynch H T, Lynch M L, Pester J, Fusaro R M. The cancer family syndrome.  Arch Intern Med. 1981;  141 607-611
• 129 Mecklin J-P, Jarvinen H J. Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer).  Cancer. 1991;  68 1109-1112
• 130 Watson P, Lynch H T. Extracolonic cancer in hereditary non-polyposis colorectal cancer.  Cancer. 1993;  71 677-685
• 131 Burke W, Petersen G, Lynch P et al.. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colorectal cancer. Cancer Genetics Studies Consortium.  JAMA. 1997;  277 915-919
• 132 Byers T, Levin B, Rothenberger D et al.. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer. Update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer.  CA Cancer J Clin. 1997;  47 154-160
• 133 National Comprehensive Cancer Network . NCCN colorectal cancer screening practice guidelines.  Oncology. 1999;  13 152-179
• 134 Vasen H F, Mecklin J P, Watson P et al.. Surveillance in hereditary nonpolyposis colorectal cancer: an international cooperative study of 165 families. The International Collaborative Group on HNPCC.  Dis Colon Rectum. 1993;  36 1-4
• 135 Jarvinen H J, Mecklin J P, Sistonem P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colon cancer.  Gastroenterology. 1995;  108 1405-1411
• 136 Watson P, Lynch H T. Extracolonic cancer in hereditary nonpolyposis colorectal cancer.  Cancer. 1993;  71 677-685
• 137 Aarnio M, Sankila R, Pukkala E et al.. Cancer risk in mutation carriers of DNA-mismatch repair genes.  Int J Cancer. 1999;  81 214-218
• 138 Aarnio M, Mecklin J P, Aaltonem L et al.. Life-time risk of different cancers in hereditary nonpolyposis colorectal cancer (HNPCC) syndrome.  Int J Cancer. 1995;  64 430-433
• 139 Fitzgibbons R, Lynch H T, Stanislav G et al.. Recognition and treatment of patients with hereditary nonpolyposis colon cancer.  Ann Surg. 1987;  206 289-295
• 140 Rodriguez-Bigas M A, Vasen H FA, Mecklin J P et al.. Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy.  Ann Surg. 1997;  225 202-207
• 141 Baba S. HNPCC, an update.  Dis Colon Rectum. 1997;  40 S86-S95
• 142 Rodriguez-Bigas M A, Petrelli N J. Management of hereditary colon cancer syndromes. In: Saltz LB Colorectal Cancer: Multimodality Management. Totowa, NJ; Humana 2002: 99-114
• 143 Moslein G, Nelson H, Thibodeau S, Dozois R R. Rectal carcinoma in HNPCC.  Langenbecks Arch Chir Suppl Kongressbd. 1998;  115 1467-1469
• 144 Aarnio M, Merklin J P, Aaltonen L et al.. Lift-time of different cancers in HNPCC syndrome.  Int J Cancer. 1995;  64 430-433
• 145 Watson P, Vasen H FA, Mecklin J P et al.. The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer.  Am J Med. 1994;  96 516-520